PATRICK FRANCOIS

Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology LAKELAND, FL NPI 1598205403

General Payments — all program years on this page

$1,160.61

  • Category: General Payments
  • Program years: PY2019–2024
  • Record count: 34
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $538.71 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $538.7119

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2019 $37.852
2020 $24.021
2021 $295.963
2022 $119.621
2023 $144.458
2024 $538.7119

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086190900 Bayer Healthcare Pharmaceuticals Inc. $21.62 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086260168 Bayer Healthcare Pharmaceuticals Inc. $16.68 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089422881 Daiichi Sankyo Inc. $17.27 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103749045 ABBVIE INC. $20.25 01/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115633841 Amgen Inc. $23.92 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115633848 Amgen Inc. $24.32 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115633858 Amgen Inc. $27.00 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118073094 Boehringer Ingelheim Pharmaceuticals, Inc. $14.57 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118073096 Boehringer Ingelheim Pharmaceuticals, Inc. $17.39 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118073098 Boehringer Ingelheim Pharmaceuticals, Inc. $21.44 07/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118893928 Otsuka America Pharmaceutical, Inc. $18.47 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118893930 Otsuka America Pharmaceutical, Inc. $29.42 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118893932 Otsuka America Pharmaceutical, Inc. $26.91 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1128482835 Bard Peripheral Vascular, Inc. $32.59 05/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1128482837 Bard Peripheral Vascular, Inc. $149.53 05/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141512399 CALLIDITAS THERAPEUTICS US INC. $17.20 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141519645 CALLIDITAS THERAPEUTICS US INC. $22.60 08/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145072742 Mallinckrodt Hospital Products Inc. $18.19 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145072746 Mallinckrodt Hospital Products Inc. $19.34 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.